NEWCELLS BIOTECH LIMITED

Dissolved Manchester

Research and experimental development on biotechnology

47 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NEWCELLS BIOTECH LIMITED

Research and experimental development on biotechnology

Founded 15 Jan 2015 Dissolved Manchester, United Kingdom 47 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 31 Oct 2026 6 months remaining
Confirmation Submitted 12 Feb 2026 Next due 29 Jan 2027 9 months remaining
Net assets £73K £4M 2024 year on year
Total assets £3M £2M 2024 year on year
Total Liabilities £3M £2M 2024 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

11th Floor Landmark St Peter's Square 1 Oxford Street Manchester M1 4PB

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NEWCELLS BIOTECH LIMITED (09389592), a dissolved life sciences and medical technology company based in Manchester, United Kingdom. Incorporated 15 Jan 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£612.06k

Decreased by £1.52M (-71%)

Net Assets

£73.31k

Decreased by £3.56M (-98%)

Total Liabilities

£2.54M

Increased by £1.53M (+153%)

Turnover

N/A

Employees

47

Increased by 3 (+7%)

Debt Ratio

97%

Increased by 75 (+341%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 2Sept 2015Unknown/Other, Seed
Investor 6Sept 2015Seed
Investor 5Feb 2021Series B

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 2,326,595 Shares £5.84m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Dec 2023389,849£1.12m£2.886
13 Dec 2023873,573£2.02m£2.309
13 Dec 2023381,185£1.10m£2.886
13 Dec 2023536,533£1.24m£2.309
13 Dec 202343,515£126k£2.886

Officers

Officers

2 active 1 resigned
Status
Muckle Secretary LimitedCorporate-secretaryUnknownUnknown24 Feb 2017Active
Nicholds, Michael John, DrDirectorBritishEngland6515 Jan 2015Active

Shareholders

Shareholders (34)

Lyle Armstrong
9.5%
700,000
The North East (erdf) Venture Capital Limited Partnership (acting By Enterprise Ventures (general Partner Ne Venture) Limited
7.8%
573,737

Persons with Significant Control

Persons with Significant Control (3)

3 Active 2 Ceased
Notified 6 Apr 2016
Nature of Control
  • Significant Influence Or Control
Active
Notified 6 Apr 2016
Nature of Control
  • Significant Influence Or Control
Active
Notified 20 Jun 2018
Nature of Control
  • Significant Influence Or Control

Nvmequity Llp

Ceased 20 Jun 2018

Ceased

Professor Lyle Armstrong

Ceased 20 Jun 2018

Ceased

Group Structure

Group Structure

NEWCELLS BIOTECH LIMITED Current Company

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Mar 2026InsolvencyLiquidation In Administration Statement Of Affairs With Form Attached
13 Mar 2026InsolvencyLiquidation Administration Notice Deemed Approval Of Proposals
24 Feb 2026InsolvencyLiquidation In Administration Proposals
20 Feb 2026AddressChange Registered Office Address Company With Date Old Address New Address
20 Feb 2026InsolvencyLiquidation In Administration Appointment Of Administrator
13 Mar 2026 Insolvency

Liquidation In Administration Statement Of Affairs With Form Attached

13 Mar 2026 Insolvency

Liquidation Administration Notice Deemed Approval Of Proposals

24 Feb 2026 Insolvency

Liquidation In Administration Proposals

20 Feb 2026 Address

Change Registered Office Address Company With Date Old Address New Address

20 Feb 2026 Insolvency

Liquidation In Administration Appointment Of Administrator

Recent Activity

Latest Activity

Liquidation In Administration Statement Of Affairs With Form Attached

1 months ago on 13 Mar 2026

Liquidation Administration Notice Deemed Approval Of Proposals

1 months ago on 13 Mar 2026

Liquidation In Administration Proposals

1 months ago on 24 Feb 2026

Change Registered Office Address Company With Date Old Address New Address

1 months ago on 20 Feb 2026

Liquidation In Administration Appointment Of Administrator

1 months ago on 20 Feb 2026